| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.74 | 0.003 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |